Group One Trading’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$1.61K 8498
2025
Q1
$1.61K Sell
100
-1,900
-95% -$35.4K ﹤0.01% 7068
2024
Q4
$34.8K Hold
2,000
﹤0.01% 5324
2024
Q3
$35.1K Sell
2,000
-7,100
-78% -$121K ﹤0.01% 4894
2024
Q2
$102K Sell
9,100
-10,000
-52% -$94.2K ﹤0.01% 3951
2024
Q1
$166K Sell
19,100
-2,100
-10% -$19.3K ﹤0.01% 3718
2023
Q4
$259K Buy
21,200
+20,900
+6,967% +$145K ﹤0.01% 3627
2023
Q3
$1.21K Buy
+300
New +$1.86K ﹤0.01% 7182
2023
Q1
Sell
-19,200
Closed -$53.2K 7780
2022
Q4
$53.2K Buy
+19,200
New +$43.1K ﹤0.01% 4947
2021
Q4
Sell
-1,800
Closed -$39K 8710
2021
Q3
$39K Buy
+1,800
New +$38.7K ﹤0.01% 6737
2018
Q3
Sell
-200
Closed -$3K 5525
2018
Q2
$3K Buy
+200
New +$3.38K ﹤0.01% 4901

Other funds holding PLSE

Group One Trading's PLSE Position: Q1 2026 in Review

Group One Trading sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 575 shares — an estimated $10.6K sold.

Group One Trading first reported a position in PLSE in Q3 2018 and held it in 15 quarters. The position peaked at $188K in Q3 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Group One Trading reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 575 Pulse Biosciences shares in Q1 2026, an estimated $10.6K.
  • Group One Trading first reported a position in Pulse Biosciences in Q3 2018 and held it in 15 quarters.
  • Group One Trading's Pulse Biosciences position peaked at $188K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.